(Q38933494)

7 September 2017

title

A computational framework for interspecies pharmacokinetics, exposure and toxicity assessment of gold nanoparticles (English)

1 reference

7 September 2017

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

author name string

Nancy A Monteiro-Riviere

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Raghuraman Kannan

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

Jim E Riviere

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

publication date

11 December 2015

1 reference

7 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

page(s)

107-119

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

Biodistribution and toxicity of engineered gold nanoparticles: a review of in vitro and in vivo studies

9 June 2020

cites work

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Toxic potential of materials at the nanolevel

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Pharmacokinetics of metallic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Uptake of engineered gold nanoparticles into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Toxico-/biokinetics of nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Nanomaterial categorization for assessing risk potential to facilitate regulatory decision-making

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Predicting the impact of biocorona formation kinetics on interspecies extrapolations of nanoparticle biodistribution modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Of mice, men and nanoparticle biocoronas: are in vitro to in vivo correlations and interspecies extrapolations realistic?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Physiologically based pharmacokinetic modeling of nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Particokinetics in vitro: dosimetry considerations for in vitro nanoparticle toxicity assessments

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

An index for characterization of nanomaterials in biological systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

A predictive toxicological paradigm for the safety assessment of nanomaterials.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

An integrated approach for the in vitro dosimetry of engineered nanomaterials

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Nano-SAR development for bioactivity of nanoparticles with considerations of decision boundaries

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Using nano-QSAR to predict the cytotoxicity of metal oxide nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Computational modeling in nanomedicine: prediction of multiple antibacterial profiles of nanoparticles using a quantitative structure-activity relationship perturbation model.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Computational tool for risk assessment of nanomaterials: novel QSTR-perturbation model for simultaneous prediction of ecotoxicity and cytotoxicity of uncoated and coated nanoparticles under multiple experimental conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Comparison of quantum dot biodistribution with a blood-flow-limited physiologically based pharmacokinetic model

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Biomedical applications of gold nanomaterials: opportunities and challenges.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Biodistribution of maltose and gum arabic hybrid gold nanoparticles after intravenous injection in juvenile swine.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Biodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Effect of surface coating on the biodistribution profile of gold nanoparticles in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Development and application of a multiroute physiologically based pharmacokinetic model for oxytetracycline in dogs and humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Estimation of placental and lactational transfer and tissue distribution of atrazine and its main metabolites in rodent dams, fetuses, and neonates with physiologically based pharmacokinetic modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Development and application of a physiologically based pharmacokinetic model for triadimefon and its metabolite triadimenol in rats and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Organ weights and blood flows of sheep and pig for physiological pharmacokinetic modelling.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Physiological parameter values for physiologically based pharmacokinetic models

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Short- and long-term distribution and toxicity of gold nanoparticles in the rat after a single-dose intravenous administration

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Evaluation of phagocytosis, bactericidal activity, and production of superoxide anion, nitric oxide, and tumor necrosis factor-alpha in Kupffer cells of neonatal pigs.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

A new approach to isolation and culture of human Kupffer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Factors controlling nanoparticle pharmacokinetics: an integrated analysis and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Gold nanoparticles cellular toxicity and recovery: effect of size, concentration and exposure time

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Development of screening assays for nanoparticle toxicity assessment in human blood: preliminary studies with charged Au nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Species extrapolation of life-stage physiologically-based pharmacokinetic (PBPK) models to investigate the developmental toxicology of ethanol using in vitro to in vivo (IVIVE) methods

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Normal structure, function, and histology of the spleen

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Laser Doppler measurements of cutaneous blood flow in ageing mice and rats

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Aging biology and geriatric clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Monocyte and macrophage heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

Facing the truth about nanotechnology in drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

In vivo integrity of polymer-coated gold nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2FNNM.15.177

21 January 2018

Identifiers

DOI

10.2217/NNM.15.177

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26653715%20AND%20SRC:MED&resulttype=core&format=json

9 June 2020

1 reference